Clinical Trial

APOE in the Predisposition to, Protection From, and Prevention of Alzheimer's Disease

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated July 20, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to track changes in the brain related to Alzheimer's disease. The results from this study will be used to develop new approaches to prevent or delay the onset of memory and thinking problems associated with Alzheimer's.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-07-29; most recent amendment 2025-07-17.
Status change: Recruiting → Enrolling by Invitation 2025-07-17
Trial Details
NCT Number NCT04994847
Lead Sponsor Banner Health
Collaborators: Mayo Clinic
Conditions Alzheimer Disease
Enrollment 300 participants
Start Date 2021-05-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-20